ABL Bio ranked among the top searched stocks for 4 days in the past month.

As of 10:30 AM on the 6th, ABL Bio is trading at 36,200 KRW, up 4.93% from the previous day. This marks a 35.07% increase compared to July 13. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.

Today, foreigners have a provisional net purchase of 27,000 shares of ABL Bio, and institutions have a net purchase of 15,000 shares. Over the past 5 days, individual investors have net purchased 362,885 shares, while foreigners and institutions have net purchased 449,110 shares and 718,181 shares, respectively.

On August 5, ABL Bio became a market issue with the headline "Rising on expectations for new drug development amid increasing COVID-19 cases."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing